Scyllo-inositol: Phase II started

Elan began the double-blind, placebo-controlled, U.S. Phase II ELND005-BPD201 trial to evaluate oral ELND005 as an adjunctive maintenance treatment to lamotrigine or valproic acid in about 400 patien...